David Rubin to Withholding Treatment
This is a "connection" page, showing publications David Rubin has written about Withholding Treatment.
Connection Strength
0.427
-
The Risk of Relapse Associated With Discontinuation of 5-Aminosalicylates in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis. Inflamm Bowel Dis. 2026 Apr 01; 32(4):661-676.
Score: 0.218
-
New Eczematous Eruption in Patients With Inflammatory Bowel Disease Who Stop Janus Kinase Inhibitors. Am J Gastroenterol. 2026 01 01; 121(1):268-273.
Score: 0.209